Conor J. Gallagher - Publications

Affiliations: 
2004 University of Toronto, Toronto, ON, Canada 

5/164 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2003 Gallagher CJ, Salter MW. Differential properties of astrocyte calcium waves mediated by P2Y1 and P2Y2 receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 6728-39. PMID 12890765 DOI: 10.1523/Jneurosci.23-17-06728.2003  0.757
2003 Fam SR, Gallagher CJ, Kalia LV, Salter MW. Differential frequency dependence of P2Y1- and P2Y2- mediated Ca 2+ signaling in astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 4437-44. PMID 12805284 DOI: 10.1523/Jneurosci.23-11-04437.2003  0.662
2000 Fam SR, Gallagher CJ, Salter MW. P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 2800-8. PMID 10751431  0.696
2000 Fam SR, Gallagher CJ, Salter MW. P2Y1 Purinoceptor-Mediated Ca2+ Signaling and Ca2+ Wave Propagation in Dorsal Spinal Cord Astrocytes The Journal of Neuroscience. 20: 2800-2808. DOI: 10.1523/Jneurosci.20-08-02800.2000  0.682
1999 Gallagher CJ, Salter MW. Nucleotide receptor signalling in spinal cord astrocytes: findings and functional implications. Progress in Brain Research. 120: 311-22. PMID 10551007 DOI: 10.1016/S0079-6123(08)63565-7  0.725
Low-probability matches (unlikely to be authored by this person)
2006 Fernandes KJ, Kobayashi NR, Gallagher CJ, Barnabé-Heider F, Aumont A, Kaplan DR, Miller FD. Analysis of the neurogenic potential of multipotent skin-derived precursors. Experimental Neurology. 201: 32-48. PMID 16678161 DOI: 10.1016/J.Expneurol.2006.03.018  0.286
1996 Chatzaki E, Bax CM, Eidne KA, Anderson L, Grudzinskas JG, Gallagher CJ. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer, and its relevance as an autocrine growth factor. Cancer Research. 56: 2059-65. PMID 8616851  0.205
1994 Chatzaki E, Gallagher CJ, Iles RK, Ind TE, Nouri AM, Bax CM, Grudzinskas JG. Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. British Journal of Cancer. 69: 1010-4. PMID 7515261 DOI: 10.1038/bjc.1994.198  0.165
1983 Crumpton MJ, Owens RJ, Gallagher CJ, Davies AA. The cell surface and its metabolism. The Journal of Pathology. 141: 235-48. PMID 6363647 DOI: 10.1002/Path.1711410305  0.147
1984 Owens RJ, Gallagher CJ, Crumpton MJ. Cellular distribution of p68, a new calcium-binding protein from lymphocytes. The Embo Journal. 3: 945-52. PMID 6376118 DOI: 10.1002/J.1460-2075.1984.Tb01912.X  0.103
1994 Seymour MT, Mansi JL, Gallagher CJ, Gore ME, Harper PG, Evans TR, Edmonds PM, Slevin ML. Protracted oral etoposide in epithelial ovarian cancer: a phase II study in patients with relapsed or platinum-resistant disease. British Journal of Cancer. 69: 191-5. PMID 8286205 DOI: 10.1038/bjc.1994.33  0.088
2009 Blevins-Primeau AS, Sun D, Chen G, Sharma AK, Gallagher CJ, Amin S, Lazarus P. Functional significance of UDP-glucuronosyltransferase variants in the metabolism of active tamoxifen metabolites. Cancer Research. 69: 1892-900. PMID 19244109 DOI: 10.1158/0008-5472.Can-08-3708  0.085
1996 Jeyarajah AR, Gallagher CJ, Blake PR, Oram DH, Dowsett M, Fisher C, Oliver RT. Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecologic Oncology. 63: 47-52. PMID 8898167 DOI: 10.1006/gyno.1996.0276  0.074
2010 Gallagher CJ, Balliet RM, Sun D, Chen G, Lazarus P. Sex differences in UDP-glucuronosyltransferase 2B17 expression and activity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 2204-9. PMID 20810538 DOI: 10.1124/Dmd.110.035345  0.068
2006 Gallagher CJ, Gordon CJ, Langefeld CD, Mychaleckyj JC, Freedman BI, Rich SS, Bowden DW, Sale MM. Association of the mu-opioid receptor gene with type 2 diabetes mellitus in an African American population. Molecular Genetics and Metabolism. 87: 54-60. PMID 16140553 DOI: 10.1016/J.Ymgme.2005.07.013  0.067
2014 Moroskat M, Gleeson SA, Sharp RJ, Simonetti A, Gallagher CJ. The geology of the carbonate-hosted Blende Ag-Pb-Zn deposit, Wernecke Mountains, Yukon, Canada Mineralium Deposita. DOI: 10.1007/S00126-014-0525-4  0.065
2010 Gallagher CJ, Anna K. What date would you like carved in stone? Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 61-64. DOI: 10.1017/CBO9780511730092.015  0.062
1997 Papamichael D, Gallagher CJ, Oliver RT, Johnson PW, Waxman J. Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter. British Journal of Cancer. 75: 606-7. PMID 9052419  0.055
2021 Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ. Overview of DaxibotulinumtoxinA for Injection: A Novel Formulation of Botulinum Toxin Type A. Drugs. 81: 2091-2101. PMID 34787840 DOI: 10.1007/s40265-021-01631-w  0.055
2009 Balliet RM, Chen G, Gallagher CJ, Dellinger RW, Sun D, Lazarus P. Characterization of UGTs active against SAHA and association between SAHA glucuronidation activity phenotype with UGT genotype. Cancer Research. 69: 2981-9. PMID 19318555 DOI: 10.1158/0008-5472.Can-08-4143  0.053
2009 Yang X, Liang SH, Weyant DM, Lazarus P, Gallagher CJ, Omiecinski CJ. The expression of human microsomal epoxide hydrolase is predominantly driven by a genetically polymorphic far upstream promoter. The Journal of Pharmacology and Experimental Therapeutics. 330: 23-30. PMID 19364907 DOI: 10.1124/Jpet.109.150870  0.053
2010 Balme MR, Gallagher CJ, Page DP, Murray JB, Muller JP, Kim JR. The Western Elysium Planitia Paleolake Lakes On Mars. 275-305. DOI: 10.1016/B978-0-444-52854-4.00010-6  0.052
2007 Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP, Lazarus P. The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians. Cancer Detection and Prevention. 31: 310-5. PMID 17935910 DOI: 10.1016/J.Cdp.2007.07.005  0.052
2019 Bertucci V, Solish N, Kaufman-Janette J, Yoelin S, Shamban A, Schlessinger J, Snyder D, Gallagher C, Liu Y, Shears G, Rubio RG. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: Pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). Journal of the American Academy of Dermatology. PMID 31791824 DOI: 10.1016/j.jaad.2019.06.1313  0.049
1991 Gallagher CJ, Oliver RT, Oram DH, Fowler CG, Blake PR, Mantell BS, Slevin ML, Hope-Stone HF. A new treatment for endometrial cancer with gonadotrophin releasing-hormone analogue. British Journal of Obstetrics and Gynaecology. 98: 1037-41. PMID 1751436 DOI: 10.1111/j.1471-0528.1991.tb15343.x  0.048
1988 Gallagher CJ. Central line placement. Critical Care Medicine. 16: 733. PMID 3371052  0.045
2002 Slater S, Shamash J, Wilson P, Gallagher CJ, Slevin ML. Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers - a new active regimen. British Journal of Cancer. 87: 850-3. PMID 12373598 DOI: 10.1038/sj.bjc.6600553  0.045
2007 Gallagher CJ, Langefeld CD, Gordon CJ, Campbell JK, Mychaleckyj JC, Mychalecky JC, Bryer-Ash M, Rich SS, Bowden DW, Sale MM. Association of the estrogen receptor-alpha gene with the metabolic syndrome and its component traits in African-American families: the Insulin Resistance Atherosclerosis Family Study. Diabetes. 56: 2135-41. PMID 17513703 DOI: 10.2337/Db06-1017  0.044
1996 Bax CM, Chatzaki E, Davies S, Gallagher CJ. Elucidating the role of gonadotrophins in endometrial cancer cell growth. Biochemical Society Transactions. 24: 443S. PMID 8878987  0.043
1983 Gallagher CJ, Knowles GK, Habeshaw JA, Green M, Malpas JS, Lister TA. Early involvement of the bronchi in patients with malignant lymphoma. British Journal of Cancer. 48: 777-81. PMID 6652018 DOI: 10.1038/bjc.1983.266  0.041
1989 Schwieger IM, Gallagher CJ, Finlayson DC, Daly WL, Maher KL. Incidence of Cell-Saver contamination during cardiopulmonary bypass. The Annals of Thoracic Surgery. 48: 51-3. PMID 2764600 DOI: 10.1016/0003-4975(89)90175-6  0.041
2016 Carruthers A, Bruce S, Cox SE, Kane MA, Lee E, Gallagher CJ. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow's Feet Lines: A Review. Aesthetic Surgery Journal / the American Society For Aesthetic Plastic Surgery. PMID 26979457 DOI: 10.1093/asj/sjw025  0.04
2013 Naumann M, Boo LM, Ackerman AH, Gallagher CJ. Immunogenicity of botulinum toxins. Journal of Neural Transmission (Vienna, Austria : 1996). 120: 275-90. PMID 23008029 DOI: 10.1007/s00702-012-0893-9  0.04
1992 Gallagher CJ. The role of gonadotrophin-releasing hormone analogues in the management of prostate cancer. Clinical Oncology (Royal College of Radiologists (Great Britain)). 4: 137-8. PMID 1586629 DOI: 10.1016/S0936-6555(05)81072-6  0.039
1987 Gallagher CJ, Cairnduff F, Smith IE. High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancer. European Journal of Cancer & Clinical Oncology. 23: 1895-900. PMID 2963746 DOI: 10.1016/0277-5379(87)90056-3  0.038
2007 Gallagher CJ, Keene KL, Mychaleckyj JC, Langefeld CD, Hirschhorn JN, Henderson BE, Gordon CJ, Freedman BI, Rich SS, Bowden DW, Sale MM. Investigation of the estrogen receptor-alpha gene with type 2 diabetes and/or nephropathy in African-American and European-American populations. Diabetes. 56: 675-84. PMID 17327435 DOI: 10.2337/Db06-0303  0.038
2014 Angstadt AY, Hartman TJ, Lesko SM, Muscat JE, Zhu J, Gallagher CJ, Lazarus P. The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions. Genes, Chromosomes & Cancer. 53: 454-66. PMID 24822274 DOI: 10.1002/Gcc.22157  0.038
2023 Dover JS, Solish N, Gross TM, Gallagher CJ, Brown J. Bridging the Gap: Sustained Treatment Effect of Glabellar Lines With Twice-A-Year Treatment With DaxibotulinumtoxinA. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 37384899 DOI: 10.1097/DSS.0000000000003852  0.038
2019 Alexis AF, Grimes P, Boyd C, Downie J, Drinkwater A, Garcia JK, Gallagher CJ. Racial and Ethnic Differences in Self-Assessed Facial Aging in Women: Results From a Multinational Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 31702594 DOI: 10.1097/DSS.0000000000002237  0.037
1982 Bell R, Gallagher CJ, Ford J, Malpas JS, Lister TA. Phase II study of a high-dose regimen of cyclophosphamide and prednisolone in advanced non-Hodgkin's lymphoma of favorable histologic type. Cancer Treatment Reports. 66: 377-80. PMID 7055819  0.036
2015 Modesto JL, Hull A, Angstadt AY, Berg A, Gallagher CJ, Lazarus P, Muscat JE. NNK reduction pathway gene polymorphisms and risk of lung cancer. Molecular Carcinogenesis. 54: E94-E102. PMID 24976539 DOI: 10.1002/Mc.22187  0.036
1999 Shamash J, Oliver RT, Ong J, Raja M, Edmonds P, Gallagher CJ, Ostrowski MJ, LeVay J, Williams M. Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 10: 685-92. PMID 10442191 DOI: 10.1023/A:1008318612005  0.035
2010 Chen G, Giambrone NE, Dluzen DF, Muscat JE, Berg A, Gallagher CJ, Lazarus P. Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms. Cancer Research. 70: 7543-52. PMID 20876810 DOI: 10.1158/0008-5472.Can-09-4582  0.035
2013 Fulford-Smith A, Gallagher CJ, Brin MF. Multicentre, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 39: 1118-9. PMID 23725480 DOI: 10.1111/dsu.12101  0.034
2013 Ashmore JH, Lesko SM, Muscat JE, Gallagher CJ, Berg AS, Miller PE, Hartman TJ, Lazarus P. Association of dietary and supplemental folate intake and polymorphisms in three FOCM pathway genes with colorectal cancer in a population-based case-control study. Genes, Chromosomes & Cancer. 52: 945-53. PMID 23893618 DOI: 10.1002/Gcc.22089  0.034
1989 Gallagher CJ, Wiltshaw E, Coleman RE, Harper PG. A dose escalation study of carboplatin and ifosfamide in advanced ovarian cancer. Cancer Chemotherapy and Pharmacology. 24: 54-7. PMID 2655961 DOI: 10.1007/BF00254106  0.034
2022 Cotofana S, Solish N, Gallagher C, Beleznay K, Hernandez CA, Bertucci V. The Anatomy behind Eyebrow Positioning: A Clinical Guide Based on Current Anatomic Concepts. Plastic and Reconstructive Surgery. PMID 35139063 DOI: 10.1097/PRS.0000000000008966  0.034
1993 Dhaliwal HS, Rohatiner AZ, Gregory W, Richards MA, Johnson PW, Whelan JS, Gallagher CJ, Matthews J, Ganesan TS, Barnett MJ. Combination chemotherapy for intermediate and high grade non-Hodgkin's lymphoma. British Journal of Cancer. 68: 767-74. PMID 8398705 DOI: 10.1038/bjc.1993.425  0.034
1985 Richards MA, Barnett MJ, Waxman JH, Rohatiner AZ, Dhaliwal HS, Gallagher CJ, Lister TA. The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma. Seminars in Oncology. 12: 223-6. PMID 4012341  0.034
2010 Mansi JL, Yellowlees A, Lipscombe J, Earl HM, Cameron DA, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Evans TR. Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. Breast Cancer Research and Treatment. 122: 787-94. PMID 20559708 DOI: 10.1007/s10549-010-0989-6  0.034
2005 Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Mansi JL. Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2988-95. PMID 15860854 DOI: 10.1200/JCO.2005.06.156  0.032
1995 Boshoff C, Oliver RT, Gallagher CJ, Ong J. Accelerated cisplatin-based chemotherapy for advanced bladder cancer. European Journal of Cancer (Oxford, England : 1990). 31: 1633-6. PMID 7488414 DOI: 10.1016/0959-8049(95)00201-S  0.031
2012 Glogau R, Kane M, Beddingfield F, Somogyi C, Lei X, Caulkins C, Gallagher C. OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar lines. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 38: 1794-803. PMID 23106853 DOI: 10.1111/j.1524-4725.2012.02582.x  0.031
2018 Keaney TC, Anolik R, Braz A, Eidelman M, Eviatar JA, Green JB, Jones DH, Narurkar VA, Rossi AM, Gallagher CJ. The Male Aesthetic Patient: Facial Anatomy, Concepts of Attractiveness, and Treatment Patterns. Journal of Drugs in Dermatology : Jdd. 17: 19-28. PMID 29320584  0.03
2008 Gallagher CJ, Reznek RH. Cancer of unknown primary site. Clinical Medicine (London, England). 8: 451-4. PMID 18724619 DOI: 10.7861/CLINMEDICINE.8-4-451  0.03
2014 Marsh WA, Monroe DM, Brin MF, Gallagher CJ. Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia. Bmc Neurology. 14: 91. PMID 24767576 DOI: 10.1186/1471-2377-14-91  0.03
2000 Mulatero C, McClaren BR, Mason M, Oliver RT, Gallagher CJ. Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma. British Journal of Cancer. 83: 1612-6. PMID 11104554 DOI: 10.1054/bjoc.2000.1480  0.03
2010 Leak TS, Langefeld CD, Keene KL, Gallagher CJ, Lu L, Mychaleckyj JC, Rich SS, Freedman BI, Bowden DW, Sale MM. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. Bmc Medical Genetics. 11: 22. PMID 20144192 DOI: 10.1186/1471-2350-11-22  0.03
2022 Solish N, Kane MAC, Biesman BS, Brown J, Gallagher CJ. Impact of DaxibotulinumtoxinA for Injection on Brow Position and Frontalis Muscle Activity Following Treatment of Glabellar Lines. Aesthetic Surgery Journal. PMID 36095026 DOI: 10.1093/asj/sjab362  0.029
2008 Chen G, Dellinger RW, Gallagher CJ, Sun D, Lazarus P. Identification of a prevalent functional missense polymorphism in the UGT2B10 gene and its association with UGT2B10 inactivation against tobacco-specific nitrosamines. Pharmacogenetics and Genomics. 18: 181-91. PMID 18300939 DOI: 10.1097/Fpc.0B013E3282F4Dbdd  0.029
1991 Jones AL, Dowsett MJ, Powles TJ, Gallagher CJ, Coombes RC. Treatment of advanced breast cancer with miconazole: a potential inhibitor of peripheral oestrogen synthesis. European Journal of Cancer (Oxford, England : 1990). 27: 301. PMID 1827318 DOI: 10.1016/0277-5379(91)90530-Q  0.028
2023 Humphrey S, Dover JS, Bowsher RR, Clancy A, Liu Y, Prawdzik G, Gallagher CJ. Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines. Aesthetic Surgery Journal. PMID 37051886 DOI: 10.1093/asj/sjad101  0.028
1998 Kamdar RH, Oliver RT, Othieno-Abinya N, Gallagher CJ, Slevin ML. Geographical epidemiology of ovarian and testicular germ cell cancers. British Journal of Cancer. 78: 1401. PMID 9836468  0.028
2011 McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Bucur A, Bencko V, Holcatova I, ... ... Gallagher CJ, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. Plos Genetics. 7: e1001333. PMID 21437268 DOI: 10.1371/Journal.Pgen.1001333  0.027
2019 Alexis AF, Few J, Callender VD, Grimes P, Downie J, Boyd C, Gallagher CJ. Myths and Knowledge Gaps in the Aesthetic Treatment of Patients With Skin of Color Journal of Drugs in Dermatology : Jdd. 18: 616-622. PMID 31329382  0.027
2023 Dowdy SF, Gallagher CJ, Vitarella D, Brown J. A technology evaluation of the atypical use of a CPP-containing peptide in the formulation and performance of a clinical botulinum toxin product. Expert Opinion On Drug Delivery. 20: 1157-1166. PMID 37847051 DOI: 10.1080/17425247.2023.2251399  0.027
1995 Oliver RT, Gallagher CJ. Intermittent endocrine therapy and its potential for chemoprevention of prostate cancer. Cancer Surveys. 23: 191-207. PMID 7621458  0.027
1990 Hunter RL, Papadea C, Gallagher CJ, Finlayson DC, Check IJ. Increased whole blood viscosity during coronary artery bypass surgery. Studies to evaluate the effects of soluble fibrin and poloxamer 188. Thrombosis and Haemostasis. 63: 6-12. PMID 2339361  0.027
2024 Solish N, Kane MAC, Brown J, Gallagher CJ. Optimized Aesthetic Outcomes When Treating Glabellar Lines with Botulinum Toxin Type A: GLO 3 + 2: A Precise Technique Based on Anatomy. Plastic and Reconstructive Surgery. Global Open. 12: e5650. PMID 38440368 DOI: 10.1097/GOX.0000000000005650  0.027
2008 Bhattacharyya M, Ryan D, Carpenter R, Vinnicombe S, Gallagher CJ. Using MRI to plan breast-conserving surgery following neoadjuvant chemotherapy for early breast cancer. British Journal of Cancer. 98: 289-93. PMID 18219287 DOI: 10.1038/sj.bjc.6604171  0.027
2009 Balme MR, Gallagher CJ, Page DP, Murray JB, Muller JP. Sorted stone circles in Elysium Planitia, Mars: Implications for recent martian climate Icarus. 200: 30-38. DOI: 10.1016/j.icarus.2008.11.010  0.026
2022 Brown J, Herrmann JE, Gallagher CJ. Important Considerations in the High-Dose Toxins Discussion. Aesthetic Surgery Journal. Open Forum. 4: ojac031. PMID 35592183 DOI: 10.1093/asjof/ojac031  0.026
2000 Shamash J, O'Doherty CA, Oliver RT, Kelsey S, Gupta RK, Gallagher CJ, Newland AC, Lister TA. Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours? Acta Oncologica (Stockholm, Sweden). 39: 857-63. PMID 11145445 DOI: 10.1080/028418600750063622  0.025
2013 Angstadt AY, Berg A, Zhu J, Miller P, Hartman TJ, Lesko SM, Muscat JE, Lazarus P, Gallagher CJ. The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk. Cancer. 119: 2477-85. PMID 23575887 DOI: 10.1002/Cncr.28009  0.025
1998 Papamichael D, Seymour MT, Penson RT, Wilson P, Gallagher CJ, Besser GM, Slevin ML. Double modulation of 5-fluorouracil with interferon alpha-2a and high-dose leucovorin in advanced neuroendocrine tumours. European Journal of Cancer (Oxford, England : 1990). 34: 2133-4. PMID 10070325  0.025
2023 Ellis K, Thach T, Gallagher CJ. Biochemical Stability and Microbial Control of Reconstituted DaxibotulinumtoxinA-lanm for Injection. Toxins. 15. PMID 38133187 DOI: 10.3390/toxins15120683  0.024
2019 Carruthers JD, Fagien S, Joseph JH, Humphrey SD, Biesman BS, Gallagher CJ, Liu Y, Rubio RG. "DaxibotulinumtoxinA in the treatment of glabellar lines: Results from each of two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2).' Plastic and Reconstructive Surgery. PMID 31609882 DOI: 10.1097/PRS.0000000000006327  0.024
2015 Kane MA, Cox SE, Jones D, Lei X, Gallagher CJ. Heterogeneity of crow's feet line patterns in clinical trial subjects. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 41: 447-56. PMID 25789814 DOI: 10.1097/DSS.0000000000000336  0.024
2007 Leak TS, Keene KL, Langefeld CD, Gallagher CJ, Mychaleckyj JC, Freedman BI, Bowden DW, Rich SS, Sale MM. Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American population. Molecular Genetics and Metabolism. 92: 145-50. PMID 17618154 DOI: 10.1016/J.Ymgme.2007.05.014  0.024
2013 Dayan S, Baumann L, Connolly S, Silverberg N, Lei X, Gallagher C. Duration of Clinical Efficacy of OnabotulinumtoxinA-Purified Neurotoxin Complex in Crow’s Feet Lines Plastic and Reconstructive Surgery. 132: 101-102. DOI: 10.1097/01.prs.0000435977.40415.57  0.022
2010 Gallagher CJ, Nguyen K. Bad airway in the Andes Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 23-27. DOI: 10.1017/CBO9780511730092.007  0.022
2010 Gallagher CJ, Coleman D. Wedge is 18; he must be full Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 28-33. DOI: 10.1017/CBO9780511730092.008  0.021
2020 Green JB, Mariwalla K, Coleman K, Ablon G, Weinkle SH, Gallagher CJ, Vitarella D, Rubio RG. A Large, Open-Label, Phase 3 Safety Study of DaxibotulinumtoxinA for Injection in Glabellar Lines: A Focus on Safety From the SAKURA 3 Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 32773447 DOI: 10.1097/DSS.0000000000002463  0.021
2015 Ashmore JH, Gallagher CJ, Lesko SM, Muscat JE, Hartman TJ, Lazarus P. No association between vitamin D intake, VDR polymorphisms, and colorectal cancer in a population-based case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26224799 DOI: 10.1158/1055-9965.Epi-15-0284  0.021
2016 Baumann L, Dayan S, Connolly S, Silverberg N, Lei X, Drinkwater A, Gallagher CJ. Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 27110893 DOI: 10.1097/DSS.0000000000000757  0.021
2004 Penson RT, Dignan F, Seiden MV, Lee H, Gallagher CJ, Matulonis UA, Olson K, Gibbens I, Gore ME. Attitudes to chemotherapy in patients with ovarian cancer. Gynecologic Oncology. 94: 427-35. PMID 15297184 DOI: 10.1016/j.ygyno.2004.05.034  0.021
1982 Gallagher CJ, Copplestone A, Meikle JD, Lister TA. The treatment of disseminated non-Hodgkin's lymphoma of unfavourable histology. Cancer Chemotherapy and Pharmacology. 8: 237-41. PMID 7105385 DOI: 10.1007/BF00255490  0.02
2008 Gallagher CJ, Kadlubar FF, Muscat JE, Ambrosone CB, Lang NP, Lazarus P. The UGT2B17 gene deletion polymorphism and risk of prostate cancer: A case-control study in Caucasians Cancer Detection and Prevention. 32: 186-187. DOI: 10.1016/J.Cdp.2008.08.005  0.02
2013 Banegas RA, Farache F, Rancati A, Chain M, Gallagher CJ, Chapman MA, Caulkins CA. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina. Aesthetic Surgery Journal / the American Society For Aesthetic Plastic Surgery. 33: 1039-45. PMID 23990584 DOI: 10.1177/1090820X13503475  0.02
2021 Cohen JL, Green LJ, Beer KR, Liu Y, Gallagher CJ. Prior Botulinum Toxin Treatment Does Not Impact Efficacy or Safety in Clinical Trials: Analysis of DaxibotulinumtoxinA for Injection in the SAKURA Program. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 33587381 DOI: 10.1097/DSS.0000000000002877  0.02
2008 Aoki KR, Irvine R, Gallagher C. Re: Botox produces functional weakness in non-injected muscles adjacent to the target muscle. Journal of Biomechanics. 41: 2066-7; author reply. PMID 18508061 DOI: 10.1016/j.jbiomech.2008.03.030  0.02
2007 Benani JC, Gallagher CJ, Ordemann BF, Sawhney JS, Solomon CS, Scherer WT. Process of site selection for handbook on benefits of regional transportation collaboration Proceedings of the 2006 Ieee Systems and Information Engineering Design Symposium, Sieds'06. 202-206. DOI: 10.1109/SIEDS.2006.278676  0.02
2020 Fabi SG, Cohen JL, Green LJ, Dhawan S, Kontis TC, Baumann L, Gross TM, Gallagher CJ, Brown J, Rubio RG. DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 32773446 DOI: 10.1097/DSS.0000000000002531  0.019
2017 Humphrey S, Jacky B, Gallagher CJ. Preventive, Cumulative Effects of Botulinum Toxin Type A in Facial Aesthetics Dermatologic Surgery. 43: S244-S251. DOI: 10.1097/DSS.0000000000001404  0.019
2005 Sale MM, Freedman BI, Hicks PJ, Williams AH, Langefeld CD, Gallagher CJ, Bowden DW, Rich SS. Loci contributing to adult height and body mass index in African American families ascertained for type 2 diabetes. Annals of Human Genetics. 69: 517-27. PMID 16138910 DOI: 10.1046/J.1529-8817.2005.00176.X  0.019
2011 Jones NR, Spratt TE, Berg AS, Muscat JE, Lazarus P, Gallagher CJ. Association studies of excision repair cross-complementation group 1 (ERCC1) haplotypes with lung and head and neck cancer risk in a Caucasian population. Cancer Epidemiology. 35: 175-81. PMID 20863778 DOI: 10.1016/J.Canep.2010.08.007  0.019
1995 Oliver RT, Joseph JV, Gallagher CJ. Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in man. Urologia Internationalis. 54: 226-9. PMID 7610506 DOI: 10.1159/000282729  0.019
2023 Gallagher CJ, Bowsher RR, Clancy A, Dover JS, Humphrey S, Liu Y, Prawdzik G. Clinical Immunogenicity of DaxibotulinumtoxinA for Injection in Glabellar Lines: Pooled Data from the SAKURA Phase 3 Trials. Toxins. 15. PMID 36668880 DOI: 10.3390/toxins15010060  0.019
2015 Butterwick K, Marmur E, Narurkar V, Cox SE, Joseph JH, Sadick NS, Tedaldi R, Wheeler S, Kolodziejczyk JK, Gallagher CJ. HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 41: 1351-60. PMID 26606435 DOI: 10.1097/DSS.0000000000000576  0.018
2015 Rivers JK, Bertucci V, McGillivray W, Muhn C, Rosen N, Solish N, Weichman BM, Wheeler S, Daniels SR, Gallagher CJ. Subject satisfaction with onabotulinumtoxinA treatment of glabellar and lateral canthal lines using a new patient-reported outcome measure. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 41: 950-9. PMID 26218728 DOI: 10.1097/DSS.0000000000000424  0.018
2016 Moe AM, Breitborde NJ, Shakeel MK, Gallagher CJ, Docherty NM. Idea density in the life-stories of people with schizophrenia: Associations with narrative qualities and psychiatric symptoms. Schizophrenia Research. PMID 26925799 DOI: 10.1016/J.Schres.2016.02.016  0.018
2012 Saha A, Varughese M, Gallagher CJ, Orphanos G, Wilson P, Oram D, Jeyarajah A, Reynolds K, Shepherd J, McCormack M, Olaitan A, McDonald N, Mould T, McNeish I, Ledermann JA. Primary chemotherapy for inoperable ovarian, fallopian tube, or primary peritoneal cancer with or without delayed debulking surgery. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 22: 566-72. PMID 22426404 DOI: 10.1097/IGC.0b013e318247727f  0.018
2015 Narurkar V, Shamban A, Sissins P, Stonehouse A, Gallagher C. Facial treatment preferences in aesthetically aware women. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. S153-60. PMID 25828040 DOI: 10.1097/DSS.0000000000000293  0.018
2022 Bertucci V, Carruthers JD, Sherman DD, Gallagher CJ, Brown J. Integrative Assessment for Optimizing Aesthetic Outcomes When Treating Glabellar Lines With Botulinum Toxin Type A: An Appreciation of the Role of the Frontalis. Aesthetic Surgery Journal. PMID 36322138 DOI: 10.1093/asj/sjac267  0.018
2015 Del Rosso JQ, Kircik L, Gallagher CJ. Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris. The Journal of Clinical and Aesthetic Dermatology. 8: 31-7. PMID 25610522  0.017
2018 Dayan S, Rivkin A, Sykes JM, Teller CF, Weinkle SH, Shumate GT, Gallagher CJ. Aesthetic Treatment Positively Impacts Social Perception: Analysis of Subjects From the HARMONY Study. Aesthetic Surgery Journal. PMID 30239596 DOI: 10.1093/asj/sjy239  0.017
2017 Humphrey S, Jacky B, Gallagher CJ. Preventive, Cumulative Effects of Botulinum Toxin Type A in Facial Aesthetics. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 43: S244-S251. PMID 33065950 DOI: 10.1097/DSS.0000000000001404  0.017
2014 Yoelin SG, Fagien S, Cox SE, Davis PG, Campo A, Caulkins CA, Gallagher CJ. A retrospective review and observational study of outcomes and safety of bimatoprost ophthalmic solution 0.03% for treating eyelash hypotrichosis. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 40: 1118-24. PMID 25229783 DOI: 10.1097/01.DSS.0000452658.83001.d9  0.017
2017 Goodman GJ, Armour KS, Kolodziejczyk JK, Santangelo S, Gallagher CJ. Comparison of self-reported signs of facial ageing among Caucasian women in Australia versus those in the USA, the UK and Canada. The Australasian Journal of Dermatology. PMID 28397327 DOI: 10.1111/ajd.12637  0.016
1998 Adams M, Calvert AH, Carmichael J, Clark PI, Coleman RE, Earl HM, Gallagher CJ, Ganesan TS, Gore ME, Graham JD, Harper PG, Jayson GC, Kaye SB, Ledermann JA, Osborne RJ, et al. Chemotherapy for ovarian cancer--a consensus statement on standard practice. British Journal of Cancer. 78: 1404-6. PMID 9836470  0.016
2024 Faivre J, Wu K, Gallet M, Sparrow J, Bourdon F, Gallagher CJ. Comparison of Hyaluronidase-Mediated Degradation Kinetics of Commercially Available Hyaluronic Acid Fillers In Vitro. Aesthetic Surgery Journal. PMID 38366708 DOI: 10.1093/asj/sjae032  0.016
2023 Taylor S, Weinkle S, Kaufman-Janette J, Gallagher CJ, Kooken K, Brown J. Effectiveness and Safety of Resilient Hyaluronic Acid (RHA) Dermal Fillers for the Correction of Moderate-to-Severe Nasolabial Folds in People of Color: Post Hoc Subgroup Analyses of US Pivotal Clinical Data. Aesthetic Surgery Journal. PMID 37556827 DOI: 10.1093/asj/sjad251  0.016
2010 Mikse OR, Blake DC, Jones NR, Sun YW, Amin S, Gallagher CJ, Lazarus P, Weisz J, Herzog CR. FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinoma. Cancer Research. 70: 6205-15. PMID 20631076 DOI: 10.1158/0008-5472.Can-09-4008  0.016
2015 Rivers JK, Bertucci V, McGillivray W, Muhn C, Rosen N, Solish N, Weichman BM, Wheeler S, Daniels SR, Gallagher CJ. Subject Satisfaction with OnabotulinumtoxinA Treatment of Glabellar and Lateral Canthal Lines Using a New Patient-Reported Outcome Measure Dermatologic Surgery. 41: 950-959. DOI: 10.1097/DSS.0000000000000424  0.015
1987 Gallagher CJ, Lister TA. Follicular non-Hodgkin's lymphoma. BaillièRe's Clinical Haematology. 1: 141-55. PMID 3327551 DOI: 10.1016/S0950-3536(87)80048-3  0.015
2017 Weinkle SH, Werschler WP, Teller CF, Sykes JM, Shamban A, Rivkin A, Narurkar VA, Kaminer MS, Dayan S, Cohen JL, Gallagher CJ. Impact of Comprehensive, Minimally Invasive, Multimodal Aesthetic Treatment on Satisfaction With Facial Appearance: The HARMONY Study. Aesthetic Surgery Journal. PMID 29244069 DOI: 10.1093/asj/sjx179  0.015
1986 Gallagher CJ, Gregory WM, Jones AE, Stansfeld AG, Richards MA, Dhaliwal HS, Malpas JS, Lister TA. Follicular lymphoma: prognostic factors for response and survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1470-80. PMID 3531422  0.014
2007 Gallagher CJ, Muscat JE, Hicks AN, Zheng Y, Dyer AM, Chase GA, Richie J, Lazarus P. The UDP-glucuronosyltransferase 2B17 gene deletion polymorphism: sex-specific association with urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol glucuronidation phenotype and risk for lung cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 823-8. PMID 17416778 DOI: 10.1158/1055-9965.Epi-06-0823  0.014
2011 Bargery AS, Balme MR, Warner N, Gallagher CJ, Gupta S. A background to Mars exploration and research Geological Society Special Publication. 356: 5-20. DOI: 10.1144/SP356.2  0.014
2016 Narurkar VA, Cohen JL, Dayan S, Kaminer MS, Rivkin A, Shamban A, Sykes JM, Teller CF, Weinkle SH, Werschler WP, Drinkwater A, Pucci ML, Gallagher CJ. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 42: S177-S191. PMID 27128246 DOI: 10.1097/DSS.0000000000000743  0.013
1992 Leahy MG, Pitfield D, Popert S, Gallagher CJ, Oliver RT. Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration. European Journal of Cancer (Oxford, England : 1990). 28: 1049-51. PMID 1627372 DOI: 10.1016/0959-8049(92)90453-9  0.013
1991 Lubarsky DA, Gallagher CJ, Berend JL. Secondary polycythemia does not increase the risk of perioperative hemorrhagic or thrombotic complications. Journal of Clinical Anesthesia. 3: 99-103. PMID 2039651 DOI: 10.1016/0952-8180(91)90004-7  0.013
2015 Carruthers A, Sadick N, Brandt F, Trindade de Almeida AR, Fagien S, Goodman GJ, Raspaldo H, Smith K, Darmody S, Gallagher CJ, Street J, Romagnano L. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 41: 693-701. PMID 25973559 DOI: 10.1097/DSS.0000000000000340  0.013
2010 Gallagher CJ, Lewis MC, Schwengel DA. Core clinical competencies in anesthesiology: A case-based approach Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 1-472. DOI: 10.1017/CBO9780511730092  0.013
2010 Gallagher CJ, Tan JM. The current status of simulation in the maintenance of certification in anesthesia. International Anesthesiology Clinics. 48: 83-99. PMID 20616639 DOI: 10.1097/AIA.0b013e3181eace5e  0.012
2011 Balme MR, Gallagher CJ, Gupta S, Murray JB. Fill and spill in Lethe Vallis: A recent flood-routing system in Elysium Planitia, Mars Geological Society Special Publication. 356: 203-227. DOI: 10.1144/SP356.11  0.012
2015 Trindade de Almeida A, Carruthers J, Cox SE, Goldman MP, Wheeler S, Gallagher CJ. Patient satisfaction and safety with aesthetic onabotulinumtoxinA after at least 5 years: a retrospective cross-sectional analysis of 4,402 glabellar treatments. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 41: S19-28. PMID 25548841 DOI: 10.1097/DSS.0000000000000275  0.012
2011 Balme MR, Bargery AS, Gallagher CJ, Gupta S. Martian Geomorphology: Introduction Geological Society Special Publication. 356: 1-3. DOI: 10.1144/SP356.1  0.011
2018 Glaser DA, Lambros V, Kolodziejczyk J, Magyar A, Dorries K, Gallagher CJ. Relationship Between Midface Volume Deficits and the Appearance of Tear Troughs and Nasolabial Folds. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 30379685 DOI: 10.1097/DSS.0000000000001684  0.011
2018 Dover JS, Shridharani SM, Bloom JD, Somogyi C, Gallagher CJ. Reduction of Submental Fat Continues Beyond 28 Days After ATX-101 Treatment: Results From a Post hoc Analysis. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 29419542 DOI: 10.1097/DSS.0000000000001484  0.011
2021 Glogau R, Kontis TC, Liu Y, Gallagher CJ. Progressive Improvement in Static Glabellar Lines After Repeated Treatment With DaxibotulinumtoxinA for Injection. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 34417396 DOI: 10.1097/DSS.0000000000003211  0.01
2019 Goodman GD, Kaufman J, Day D, Weiss R, Kawata AK, Garcia JK, Santangelo S, Gallagher CJ. Impact of Smoking and Alcohol Use on Facial Aging in Women: Results of a Large Multinational, Multiracial, Cross-sectional Survey. The Journal of Clinical and Aesthetic Dermatology. 12: 28-39. PMID 31531169  0.01
2022 Bertucci V, Green JB, Fezza JP, Brown J, Gallagher CJ. Impact of Glabellar Injection Technique With DaxibotulinumtoxinA for Injection on Brow Position. Aesthetic Surgery Journal. PMID 36322141 DOI: 10.1093/asj/sjac002  0.01
2019 Kaminer MS, Cohen JL, Shamban A, Werschler WP, Shumate GT, Drinkwater A, Gallagher CJ. Maximizing Panfacial Aesthetic Outcomes: Findings and Recommendations From the HARMONY Study. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 31834076 DOI: 10.1097/DSS.0000000000002271  0.01
2019 Taylor SC, Downie JB, Shamban A, Few J, Weichman BM, Schumacher A, Gallagher CJ. Lip and Perioral Enhancement With Hyaluronic Acid Dermal Fillers in Individuals With Skin of Color. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 30789512 DOI: 10.1097/DSS.0000000000001842  0.01
2018 Baumann L, Shridharani SM, Humphrey S, Gallagher CJ. Personal (Self) Perceptions of Submental Fat Among Adults in the United States. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. PMID 30234657 DOI: 10.1097/DSS.0000000000001648  0.01
2017 Rossi AM, Eviatar J, Green JB, Anolik R, Eidelman M, Keaney TC, Narurkar V, Jones D, Kolodziejczyk J, Drinkwater A, Gallagher CJ. Signs of Facial Aging in Men in a Diverse, Multinational Study: Timing and Preventive Behaviors. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 43: S210-S220. PMID 29064988 DOI: 10.1097/DSS.0000000000001293  0.01
2017 Taylor SC, Downie JB, Shamban A, Few J, Khan B, Schumacher A, Gallagher C. Lip and Perioral Enhancement with HA Dermal Fillers in Individuals with Fitzpatrick Skin Types IV-VI Skin the Journal of Cutaneous Medicine. 1: s79. DOI: 10.25251/skin.1.supp.78  0.01
2016 Jagdeo J, Keaney T, Narurkar V, Kolodziejczyk J, Gallagher CJ. Facial Treatment Preferences Among Aesthetically Oriented Men. Dermatologic Surgery : Official Publication For American Society For Dermatologic Surgery [Et Al.]. 42: 1155-63. PMID 27661428 DOI: 10.1097/DSS.0000000000000876  0.01
2016 Alexis AF, Burgess C, Callender VD, Herzog JL, Roberts WE, Schweiger ES, Stockton TC, Gallagher CJ. The Efficacy and Safety of Topical Dapsone Gel, 5% for the Treatment of Acne Vulgaris in Adult Females With Skin of Color. Journal of Drugs in Dermatology : Jdd. 15: 197-204. PMID 26885788  0.01
2014 Gold MH, Gallagher C. An evaluation of the benefits of a topical treatment in the improvement of photodamaged hands with age spots, freckles, and/or discolorations. Journal of Drugs in Dermatology : Jdd. 12: 1468-72. PMID 24301250  0.01
2013 Brouwer-Brolsma EM, Bischoff-Ferrari HA, Bouillon R, Feskens EJ, Gallagher CJ, Hypponen E, Llewellyn DJ, Stoecklin E, Dierkes J, Kies AK, Kok FJ, Lamberg-Allardt C, Moser U, Pilz S, Saris WH, et al. Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 24: 1567-77. PMID 23229471 DOI: 10.1007/s00198-012-2231-3  0.01
2013 Balme MR, Gallagher CJ, Hauber E. Morphological evidence for geologically young thaw of ice on Mars: A review of recent studies using high-resolution imaging data Progress in Physical Geography. 37: 289-324. DOI: 10.1177/0309133313477123  0.01
2012 Brown ME, Curtin TM, Gallagher CJ, Halfman JD. Historic nutrient loading and recent species invasions caused shifts in water quality and zooplankton demography in two Finger Lakes (New York, USA) Journal of Paleolimnology. 48: 623-639. DOI: 10.1007/s10933-012-9633-2  0.01
2011 Gallagher CJ, Balme MR. Landforms indicative of ground-ice thaw in the northern high latitudes of Mars Geological Society Special Publication. 356: 87-110. DOI: 10.1144/SP356.6  0.01
2010 Soto RG, Cormican DS, Gallagher CJ, Seidman PA. Teaching systems-based competency in anesthesiology residency: development of an education and assessment tool. Journal of Graduate Medical Education. 2: 250-9. PMID 21975630 DOI: 10.4300/JGME-D-09-00078.1  0.01
2010 Truong T, Hung RJ, Amos CI, Wu X, Bickeböller H, Rosenberger A, Sauter W, Illig T, Wichmann HE, Risch A, Dienemann H, Kaaks R, Yang P, Jiang R, Wiencke JK, ... ... Gallagher CJ, et al. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. Journal of the National Cancer Institute. 102: 959-71. PMID 20548021 DOI: 10.1093/Jnci/Djq178  0.01
2010 Gallagher CJ, Neal M. Flame on! Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 56-60. DOI: 10.1017/CBO9780511730092.014  0.01
2010 Gallagher CJ, Neal M. When were those stents placed? Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 52-55. DOI: 10.1017/CBO9780511730092.013  0.01
2010 Gallagher CJ, Corrado T. Brown-Sequard and the orthopedic knife extraction Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 46-51. DOI: 10.1017/CBO9780511730092.012  0.01
2010 Gallagher CJ, Posner E. The sin of pride after an awake intubation Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 43-45. DOI: 10.1017/CBO9780511730092.011  0.01
2010 Gallagher CJ, Posner E. Extubation wrecking a perfectly good Sunday Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 40-42. DOI: 10.1017/CBO9780511730092.010  0.01
2010 Gallagher CJ, Dubrow K. Calling across specialties Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 34-39. DOI: 10.1017/CBO9780511730092.009  0.01
2010 Gallagher CJ, Nguyen K. No Foley, no surgeon; what now? Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 18-22. DOI: 10.1017/CBO9780511730092.006  0.01
2010 Gallagher CJ, Corrado T. Pop goes the aneurysm Core Clinical Competencies in Anesthesiology: a Case-Based Approach. 11-17. DOI: 10.1017/CBO9780511730092.005  0.01
2010 Gallagher CJ, Poovathor S. Vascular Access in the Intensive Care Unit Cardiac Intensive Care. 545-557. DOI: 10.1016/B978-1-4160-3773-6.10044-8  0.01
2009 Brin MF, Tan K, Gallagher C. Differences in botulinum toxins: time to end the confusion. Journal of Cosmetic and Laser Therapy : Official Publication of the European Society For Laser Dermatology. 11: 180-1. PMID 19626521 DOI: 10.1080/14764170903137121  0.01
2009 Gallagher CJ, Ahn K, Knipe AL, Dyer AM, Richie JP, Lazarus P, Muscat JE. Association between haplotypes of manganese superoxide dismutase (SOD2), smoking, and lung cancer risk. Free Radical Biology & Medicine. 46: 20-4. PMID 18930810 DOI: 10.1016/J.Freeradbiomed.2008.09.018  0.01
2008 Gallagher CJ, Akerman RR, Castillo D, Matadial CM, Shekhter I. On the Road with the Simulator Clinical Simulation. 559-563. DOI: 10.1016/B978-012372531-8.50100-X  0.01
2007 Sahdev A, Hughes JH, Barwick T, Rockall AG, Gallagher CJ, Reznek RH. Computed tomography features of recurrent ovarian carcinoma according to time to relapse. Acta Radiologica (Stockholm, Sweden : 1987). 48: 1038-44. PMID 17957523 DOI: 10.1080/02841850701557255  0.01
2000 Shamash J, Oliver RT, Gallagher CJ, Newland AC, Lister TA, Kelsey S, Gupta RK, O'Doherty CA. Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. British Journal of Cancer. 82: 2022-3. PMID 10864212 DOI: 10.1054/bjoc.1999.1140  0.01
1994 Boshoff C, Edmonds PM, Gallagher CJ. Cuffed polyurethane catheter for ambulatory infusional chemotherapy. British Journal of Hospital Medicine. 52: 171-4. PMID 8000682  0.01
1992 Oliver RT, Raja MA, Ong J, Gallagher CJ. Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients. The Journal of Urology. 148: 1453-5; discussion 1. PMID 1279211  0.01
1984 Gallagher CJ, White FE, Tucker AK, Fry IK, Malpas JS, Lister TA. The role of computed tomography in the detection of intrathoracic lymphoma. British Journal of Cancer. 49: 621-9. PMID 6722010 DOI: 10.1038/bjc.1984.97  0.01
Hide low-probability matches.